Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Bistrup Dyreklinik ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   1.7% 1.3% 1.2% 1.0% 1.0% 1.1% 8.7% 8.5%   Credit score (0-100)   75 81 83 85 86 82 28 29   Credit rating   A A A A A A BB BB   Credit limit (kDKK)   2.1 49.6 129.0 224.2 205.4 112.6 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,539 3,741 3,904 3,620 4,146 4,250 0.0 0.0   EBITDA   840 1,090 1,226 1,270 1,092 935 0.0 0.0   EBIT   678 907 1,004 980 776 633 0.0 0.0   Pre-tax profit (PTP)   675.2 901.8 988.7 966.4 791.0 674.7 0.0 0.0   Net earnings   526.6 702.0 770.1 753.5 617.0 526.3 0.0 0.0   Pre-tax profit without non-rec. items   675 902 989 966 791 675 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   175 518 556 693 476 275 0.0 0.0   Shareholders equity total   1,117 1,819 2,089 2,343 2,460 1,786 1,036 1,036   Interest-bearing liabilities   0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,864 3,081 3,601 3,276 3,309 2,911 1,036 1,036   Net Debt   -661 -1,069 -2,045 -1,717 -715 -1,074 -936 -936     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,539 3,741 3,904 3,620 4,146 4,250 0.0 0.0   Gross profit growth   0.0% 47.3% 4.4% -7.3% 14.5% 2.5% -100.0% 0.0%   Employees   5 6 7 6 7 7 0 0   Employee growth %   0.0% 20.0% 16.7% -14.3% 16.7% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,864 3,081 3,601 3,276 3,309 2,911 1,036 1,036   Balance sheet change%   0.0% 65.3% 16.9% -9.0% 1.0% -12.0% -64.4% 0.0%   Added value   840.4 1,089.5 1,225.6 1,270.4 1,066.6 934.7 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   613 60 -283 -254 -633 -603 -275 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   26.7% 24.2% 25.7% 27.1% 18.7% 14.9% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   36.4% 36.7% 30.1% 28.5% 24.3% 21.7% 0.0% 0.0%   ROI %   54.4% 56.8% 48.5% 42.3% 32.3% 31.3% 0.0% 0.0%   ROE %   47.1% 47.8% 39.4% 34.0% 25.7% 24.8% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   59.9% 59.0% 58.0% 71.5% 74.3% 61.4% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -78.7% -98.1% -166.9% -135.1% -65.4% -114.9% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.3% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 402.4% 282.9% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.1 1.4 1.6 2.3 2.6 1.8 0.0 0.0   Current Ratio   1.5 1.6 1.7 2.5 3.0 2.1 0.0 0.0   Cash and cash equivalent   661.0 1,068.8 2,045.0 1,723.2 714.6 1,073.9 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   277.5 729.6 1,047.0 1,234.6 1,631.0 1,216.7 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   168 182 175 212 152 134 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   168 182 175 212 156 134 0 0   EBIT / employee   136 151 143 163 111 90 0 0   Net earnings / employee   105 117 110 126 88 75 0 0